Press Releases

• Q4 net sales 3.2%; organic sales1 1.2% • Q4 diluted EPS was $0.17; adjusted diluted EPS1 was $0.27 • FY’25 net sales (2.1)%; organic sales (2.2)% • FY’25 diluted EPS was $0.76;...

SUMMIT, N.J., February 4, 2026 - Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending...

SUMMIT, N.J., January 28, 2026 - Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend...

2025 results show further momentum from Powering Care strategy, supporting further strategic transformation 2026 outlook reflects continued organic growth and operating momentum as transformation...

Kenvue Brands LLC, the maker of Tylenol®, issued the following statement in response to today’s filing by the Office of the Attorney General of Texas: We are taking immediate legal action to...